HER2 Support Group Forums - View Single Post - Genentech receives FDA approval for Kadcyla to treat HER2-positive metastatic breast

News · 02-22-2013, 11:10 PM

The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new therapy for patients with HER2-positive, late-stage (metastatic) breast cancer.

More...

02-22-2013, 11:10 PM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,983	Genentech receives FDA approval for Kadcyla to treat HER2-positive metastatic breast The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new therapy for patients with HER2-positive, late-stage (metastatic) breast cancer. More...